AAAAAA

   
Results: 1-11 |
Results: 11
Natural history of hepatitis B virus infection
Authors: Forcione, DG Chung, RT Dienstag, JL
Citation: Dg. Forcione et al., Natural history of hepatitis B virus infection, CLIN GAS, 2002, pp. 41-58
Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy
Authors: McHutchison, JG Shad, JA Gordon, SC Morgan, TR Ling, MH Garaud, JJ Albrecht, JK Dienstag, JL
Citation: Jg. Mchutchison et al., Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy, J VIRAL HEP, 8(6), 2001, pp. 414-420
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region
Authors: Stuyver, LJ Locarnini, SA Lok, A Richman, DD Carman, WF Dienstag, JL Schinazi, RF
Citation: Lj. Stuyver et al., Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region, HEPATOLOGY, 33(3), 2001, pp. 751-757
Lamivudine for the treatment of chronic hepatitis B. Reply
Authors: Dienstag, JL Brown, NA
Citation: Jl. Dienstag et Na. Brown, Lamivudine for the treatment of chronic hepatitis B. Reply, N ENG J MED, 342(8), 2000, pp. 592-592
Alternative therapy Si, gene therapy no?
Authors: Dienstag, JL
Citation: Jl. Dienstag, Alternative therapy Si, gene therapy no?, GASTROENTY, 119(5), 2000, pp. 1189-1189
Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy
Authors: Dienstag, JL Schiff, ER Mitchell, M Casey, DE Gitlin, N Lissoos, T Gelb, LD Condreay, L Crowther, L Rubin, M Brown, N
Citation: Jl. Dienstag et al., Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy, HEPATOLOGY, 30(4), 1999, pp. 1082-1087
Mutations in the NS5A region do not predict interferon-responsiveness in American patients infected with genotype 1b hepatitis C virus
Authors: Chung, RT Monto, A Dienstag, JL Kaplan, LM
Citation: Rt. Chung et al., Mutations in the NS5A region do not predict interferon-responsiveness in American patients infected with genotype 1b hepatitis C virus, J MED VIROL, 58(4), 1999, pp. 353-358
Lamivudine as initial treatment for chronic hepatitis B in the United States
Authors: Dienstag, JL Schiff, ER Wright, TL Perrillo, RP Hann, HWL Goodman, Z Crowther, L Condreay, LD Woessner, M Rubin, M Brown, NA
Citation: Jl. Dienstag et al., Lamivudine as initial treatment for chronic hepatitis B in the United States, N ENG J MED, 341(17), 1999, pp. 1256-1263
Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine
Authors: Gauthier, J Bourne, EJ Lutz, MW Crowther, LM Dienstag, JL Brown, NA Condreay, LD
Citation: J. Gauthier et al., Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine, J INFEC DIS, 180(6), 1999, pp. 1757-1762
New antiviral agents for viral hepatitis: Our cup runneth over but is onlyhalf full
Authors: Dienstag, JL
Citation: Jl. Dienstag, New antiviral agents for viral hepatitis: Our cup runneth over but is onlyhalf full, GASTROENTY, 117(3), 1999, pp. 525-525
Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States
Authors: Reid, AE Koziel, MJ Aiza, I Jeffers, L Reddy, R Schiff, E Lau, JYN Dienstag, JL Liang, TJ
Citation: Ae. Reid et al., Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States, AM J GASTRO, 94(6), 1999, pp. 1619-1626
Risultati: 1-11 |